Multiple Sclerosis: Deeper Understanding of Its Pathogenesis Reveals New Targets for Therapy
- 1 March 2002
- journal article
- review article
- Published by Annual Reviews in Annual Review of Neuroscience
- Vol. 25 (1), 491-505
- https://doi.org/10.1146/annurev.neuro.25.112701.142913
Abstract
▪ Abstract Recent technological breakthroughs allowing for large-scale analysis of gene transcripts and large-scale monitoring of the immune response with protein chips are revealing new participants in the pathogenesis of multiple sclerosis. Some of these participants may be useful targets for therapy.Keywords
This publication has 43 references indexed in Scilit:
- The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating DiseaseScience, 2001
- Blockade of gamma interferon might be beneficial in MSMultiple Sclerosis Journal, 2001
- Combination of Gene Delivery and DNA Vaccination to Protect from and Reverse Th1 Autoimmune Disease via Deviation to the Th2 PathwayImmunity, 2001
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- A full genome search in multiple sclerosisNature Genetics, 1996
- A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complexNature Genetics, 1996
- A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22Nature Genetics, 1996
- Mechanisms of Immune Injury in Multiple SclerosisBrain Pathology, 1996
- Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic proteinCell, 1995
- Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosisNature, 1993